Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Glioblastoma multiforme

  • Open Access
    Overall Survival of Glioblastoma Patients Treated With a Combination of 7 Micronutrients: A Nutraceutical Trial
    HARCHARAN KAUR ROOPRAI, PATRICK LAWRENCE, KEYOUMARS ASHKAN, RONALD BEANEY, GEOFFREY J. PILKINGTON and RICHARD W. GULLAN
    Anticancer Research March 2026, 46 (3) 1599-1608; DOI: https://doi.org/10.21873/anticanres.18055
  • Open Access
    Therapy Intensity Outweighs the Prognostic Importance of the Timing of Chemoradiotherapy in Newly Diagnosed Glioblastoma Patients
    JAN LEPPERT, CLAUDIA DITZ, MAXIMILIAN GROHMANN, CHRISTIAN ZIEMANN, CHRISTINA HILLBRICHT, LARYSA LIUBICH, MARIA VITTORIA MATONE, DIRK RADES, JAN GLIEMROTH and ANASTASSIA LÖSER
    Anticancer Research October 2024, 44 (10) 4403-4412; DOI: https://doi.org/10.21873/anticanres.17269
  • Open Access
    COX-2 Acts as a Key Mediator of Trifluoperazine-induced Cell Death in U87MG Glioma Cells
    JUYEONG PARK, JOO YEON JEONG and SANG SOO KANG
    Anticancer Research December 2022, 42 (12) 5773-5781; DOI: https://doi.org/10.21873/anticanres.16084
  • You have access
    Establishment of a Novel Temozolomide Resistant Subline of Glioblastoma Multiforme Cells and Comparative Transcriptome Analysis With Parental Cells
    HAI-ANH HA, JAI-SING YANG, FUU-JEN TSAI, CHANG-WEI LI, YIH-DIH CHENG, JIANYONG LI, MANN-JEN HOUR and YU-JEN CHIU
    Anticancer Research May 2021, 41 (5) 2333-2347; DOI: https://doi.org/10.21873/anticanres.15008
  • You have access
    A New Survival Score for Patients Receiving Radiotherapy for Newly Diagnosed Glioblastoma Multiforme
    DIRK RADES, JASPAR WITTELER, STEVEN E. SCHILD, PETER TRILLENBERG, MATTEO M. BONSANTO and JAN LEPPERT
    Anticancer Research January 2021, 41 (1) 379-384; DOI: https://doi.org/10.21873/anticanres.14786
  • You have access
    Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM)
    JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research December 2020, 40 (12) 7025-7030; DOI: https://doi.org/10.21873/anticanres.14728
  • You have access
    Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature
    RUDOLF LIKAR, MARKUS KOESTENBERGER, MARTIN STULTSCHNIG and GERHARD NAHLER
    Anticancer Research October 2019, 39 (10) 5797-5801; DOI: https://doi.org/10.21873/anticanres.13783
  • You have access
    Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion
    LAWRENCE HELSON and MUHAMMED MAJEED
    Anticancer Research July 2019, 39 (7) 3423-3427; DOI: https://doi.org/10.21873/anticanres.13487
  • You have access
    Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
    MARKOS ANTONOPOULOS, STEFAAN W. VAN GOOL, DIMITRA DIONYSIOU, NORBERT GRAF and GEORGIOS STAMATAKOS
    Anticancer Research April 2019, 39 (4) 2043-2051; DOI: https://doi.org/10.21873/anticanres.13315
  • You have access
    Brainstem Glioblastoma Multiforme in a Patient with NF1
    JOHN T. FORTUNATO, BRIAN REYS, PAWAN SINGH and EDWARD PAN
    Anticancer Research August 2018, 38 (8) 4897-4900; DOI: https://doi.org/10.21873/anticanres.12804

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire